Note
Bioactivity-guided fractionation of metabolites from the crinoid Holopus rangii led to the discovery of two new phenanthroperylenequinone derivatives, gymnochromes E (1) and F (2). Gymnochrome E showed cytotoxic activity toward the NCI/ADR-Res with an IC50 of 3.5 µM. It also inhibited histone deacetylase-1 with an IC50 of 3.3 µM. Gymnochrome F was a moderate inhibitor of Myeloid cell leukemia sequence 1 (MCL-1) binding to Bak.